Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios D Anastasilakis

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
Rheumatology International|November 6, 2012
Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexateGrigorios T Sakellariou, Fares E Sayegh, Athanasios D Anastasilakis, et al.
Endocrine Connections|April 23, 2026
Exploring the Relationship Between Microplastic Exposure and Bone HealthApostolos I Gogakos, Stergios A Polyzos, Dimitrios A Anastasilakis, et al.
Nature Reviews. Endocrinology|April 20, 2026
Pathophysiology, diagnosis and management of secondary osteoporosisJulien Paccou, Elena Tsourdi, Athanasios D Anastasilakis, et al.
Journal of Clinical Medicine|November 26, 2022
Irisin and Bone in Sickness and in Health: A Narrative Review of the LiteratureElena Tsourdi, Athanasios D Anastasilakis, Lorenz C Hofbauer, et al.
Hormones (Athens, Greece)|July 11, 2016
Development and validation of an osteoporosis treatment questionnaire (OSTREQ) evaluating physicians' criteria in the choice of treatmentPolyzois Makras, Antonios Galanos, Stavroula Rizou, et al.
International Journal of Molecular Sciences|April 26, 2020
Gender Predilection in Sporadic Parathyroid AdenomasMaria P Yavropoulou, Athanasios D Anastasilakis, Argyro Panagiotakou, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 8, 2024
The comparative effect of teriparatide and denosumab on activins, follistatins, and inhibins in women with postmenopausal osteoporosisAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 26, 2025
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trialPolyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 21, 2020
Progression of Rebound-Associated Vertebral Fractures Following Denosumab Discontinuation Despite Reinstitution of Treatment: Suppressing Increased Bone Turnover May Not Be EnoughAthanasios D Anastasilakis, Georgios Trovas, Alexia Balanika, et al.
Clinical Endocrinology|March 5, 2013
Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosisPolyzois Makras, Stergios A Polyzos, Athanasios Papatheodorou, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Rheumatology International|November 6, 2012
Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexateGrigorios T Sakellariou, Fares E Sayegh, Athanasios D Anastasilakis, et al.
Endocrine Connections|April 23, 2026
Exploring the Relationship Between Microplastic Exposure and Bone HealthApostolos I Gogakos, Stergios A Polyzos, Dimitrios A Anastasilakis, et al.
Nature Reviews. Endocrinology|April 20, 2026
Pathophysiology, diagnosis and management of secondary osteoporosisJulien Paccou, Elena Tsourdi, Athanasios D Anastasilakis, et al.
Journal of Clinical Medicine|November 26, 2022
Irisin and Bone in Sickness and in Health: A Narrative Review of the LiteratureElena Tsourdi, Athanasios D Anastasilakis, Lorenz C Hofbauer, et al.
Hormones (Athens, Greece)|July 11, 2016
Development and validation of an osteoporosis treatment questionnaire (OSTREQ) evaluating physicians' criteria in the choice of treatmentPolyzois Makras, Antonios Galanos, Stavroula Rizou, et al.
International Journal of Molecular Sciences|April 26, 2020
Gender Predilection in Sporadic Parathyroid AdenomasMaria P Yavropoulou, Athanasios D Anastasilakis, Argyro Panagiotakou, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 8, 2024
The comparative effect of teriparatide and denosumab on activins, follistatins, and inhibins in women with postmenopausal osteoporosisAthanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 26, 2025
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trialPolyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 21, 2020
Progression of Rebound-Associated Vertebral Fractures Following Denosumab Discontinuation Despite Reinstitution of Treatment: Suppressing Increased Bone Turnover May Not Be EnoughAthanasios D Anastasilakis, Georgios Trovas, Alexia Balanika, et al.
Clinical Endocrinology|March 5, 2013
Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosisPolyzois Makras, Stergios A Polyzos, Athanasios Papatheodorou, et al.
Pageof 16